Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

YM-53601

Copy Product Info
😃Good
Catalog No. T26345Cas No. 182959-33-7
Alias YM53601, YM 53601

YM-53601 is a potent squalene synthase (SQS) inhibitor that inhibits adipogenic biosynthesis and lipid secretion in rodents.YM-53601 is a cholesterol-lowering agent that inhibits farnesyl diphosphate farnesyltransferase 1 (FDFT1).YM-53601 exhibits potential antiviral activity and enhances adriamycin-mediated HCC arrest and cell death in vivo. MJN228 is a lipid-based enzyme.

YM-53601

YM-53601

Copy Product Info
😃Good
Purity: 99.65%
Catalog No. T26345Alias YM53601, YM 53601Cas No. 182959-33-7
YM-53601 is a potent squalene synthase (SQS) inhibitor that inhibits adipogenic biosynthesis and lipid secretion in rodents.YM-53601 is a cholesterol-lowering agent that inhibits farnesyl diphosphate farnesyltransferase 1 (FDFT1).YM-53601 exhibits potential antiviral activity and enhances adriamycin-mediated HCC arrest and cell death in vivo. MJN228 is a lipid-based enzyme.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$163In StockIn Stock
5 mg$413In StockIn Stock
10 mg$662-In Stock
25 mg$1,320-In Stock
50 mg$2,150-In Stock
1 mL x 10 mM (in DMSO)$455-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.65%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
YM-53601 is a potent squalene synthase (SQS) inhibitor that inhibits adipogenic biosynthesis and lipid secretion in rodents.YM-53601 is a cholesterol-lowering agent that inhibits farnesyl diphosphate farnesyltransferase 1 (FDFT1).YM-53601 exhibits potential antiviral activity and enhances adriamycin-mediated HCC arrest and cell death in vivo. MJN228 is a lipid-based enzyme.
Targets&IC50
Squalene synthase (hamster liver):170 nM, HepG2 cells (guinea pig liver microsomes):46 nM, HepG2 cells (rhesus monkey liver microsomes):45 nM, HepG2 cells (human liver microsomes):79 nM, HepG2 cells (rat liver microsomes):90 nM, HepG2 cells (hamster liver microsomes):170 nM
In vitro
YM-53601 inhibited squalene synthase activity in a variety of animal and human cell lines, with IC50s of 90, 170, 46, 45, and 79 nM in liver microsomes of rat, hamster, guinea pig, rhesus monkey, and human HepG2 cells, respectively. [1]
YM-53601 inhibited the conversion of [3H] farnesyl diphosphate to [3H] squalene by squalene synthase in hamster liver with an IC50 of 170 nM. [2]
In H35 cells, 1 μM M-53601 enhanced sensitivity to toxic carotenoids, lonidamine and adriamycin, and reduced mitochondrial cholesterol levels in H35 and HepG2 cells. [4]
In vivo
YM-53601 inhibited cholesterol biosynthesis in rats at an ED50 of 32 mg/kg . [1]
In addition, in a hamster model, YM-53601 reduced plasma non-HDL cholesterol levels by approximately 70% when administered orally at 50 mg/kg/day for 5 days. [2]
YM-53601 also enhanced doxorubicin-mediated inhibition of hepatocellular carcinoma (HCC) cell proliferation and cell death in vivo. [4]
SynonymsYM53601, YM 53601
Chemical Properties
Molecular Weight372.86
FormulaC21H22ClFN2O
Cas No.182959-33-7
SmilesO(C/C(/F)=C\1/C2CCN(C1)CC2)C=3C=C4C(C=5C(N4)=CC=CC5)=CC3.Cl
Relative Density.no data available
Storage & Solubility Information
Storagekeep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (214.56 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (8.85 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.6820 mL13.4099 mL26.8197 mL134.0986 mL
5 mM0.5364 mL2.6820 mL5.3639 mL26.8197 mL
10 mM0.2682 mL1.3410 mL2.6820 mL13.4099 mL
20 mM0.1341 mL0.6705 mL1.3410 mL6.7049 mL
50 mM0.0536 mL0.2682 mL0.5364 mL2.6820 mL
100 mM0.0268 mL0.1341 mL0.2682 mL1.3410 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy YM-53601 | purchase YM-53601 | YM-53601 cost | order YM-53601 | YM-53601 chemical structure | YM-53601 in vivo | YM-53601 in vitro | YM-53601 formula | YM-53601 molecular weight